echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Interview with Professor Haiqing Song: Diagnosis strategies for the etiology of cardiogenic stroke from the latest SCAI PFO management guidelines

    Interview with Professor Haiqing Song: Diagnosis strategies for the etiology of cardiogenic stroke from the latest SCAI PFO management guidelines

    • Last Update: 2023-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The author of this article: Medical Pulse Tong Tian Association Reporting Group

    Yimaitong collates the report, please do not reprint
    it without authorization.


    In recent years, cardiogenic stroke has become more and more common, and the onset is often more acute and serious, which not only seriously affects the quality of life of patients, but also significantly reduces the survival time of stroke patients, bringing heavy burden
    to families and society.
    On August 5-7, 2022, the 8th Annual Conference of the Chinese Stroke Society and the Tiantan International Conference on Cerebrovascular Disease were held, during which Yimaitong interviewed Professor Song Haiqing from Xuanwu Hospital of Capital Medical University on the topic of "Talking about the Etiological Diagnosis Strategy of Cardiogenic Stroke from the Latest PFO Management Guidelines of SCAI".



    Medical Pulse: What are the clinical manifestations of cardiogenic stroke compared to other types of stroke, and under what circumstances do we need to consider the possibility of cardiogenic stroke?


    Professor Song Haiqing: In recent years, the prevention and treatment of stroke has undergone great changes through everyone's efforts, and the prevention and treatment of atherosclerosis-related risk factors, such as controlling hypertension, antiplatelet and lipid-lowering therapy, etc.
    , has become better and better.


    From a clinical point of view, cardiogenic stroke has some characteristics: (1) it tends to have a more acute onset, a more severe condition, and is prone to early bleeding transformation of infarction; (2) Imaging features: lesions are sometimes multiple, and often have foci
    in the cross-vascular blood supply basin.
    These signs are some important bases for clinicians to identify cardiogenic stroke early, and some auxiliary tests are needed, such as screening for atrial fibrillation, ECG or long-term ECG; When a structural defect in the heart is suspected, some cardiac imaging tests
    are done.


    Yimaitong: Could you briefly introduce the connection between cardiogenic stroke and PFO, and how should cardiogenic stroke patients with PFO be diagnosed clinically?


    Professor Song Haiqing: For cardiogenic stroke in the past, more attention was paid to non-valvular atrial fibrillation, PFO is also a kind of cardiogenic stroke, in recent years, PFO (patent foramen ovale) and stroke association has received more and more attention
    .
    There are two main reasons: on the one hand, from the current clinical evidence, there is more evidence for high-risk stroke-related PFO closure surgery, and more and more cardiologists carry out this operation; On the other hand, the detection and screening technology for right-to-left shunts is becoming more and more mature, such as the foaming experiment
    of TCD.
    Therefore, neurology, vascular ultrasound and cardiology are paying more and more attention to this problem
    .
    There is also the characteristics of PFO itself, about 1/4 of adults have this defect, and some PFO is associated with migraine and stroke, these patients often first go to the neurology department, and have become a very important part
    of cardiogenic stroke screening.


    Yimaitong: How should cardiogenic stroke patients with PFO be treated clinically?


    Professor Song Haiqing: The most important thing is to first clarify the diagnosis, whether ischemic stroke is related to cardiac stroke, and whether the cause can be determined as PFO? PFOs that cause stroke are high-risk PFOs and require active intervention to prevent stroke recurrence
    .
    For high-risk PFO, according to the current clinical evidence, it is recommended to have the conditions for closure, combined with drug therapy; For low-risk PFOs or difficulties in closing, drugs or other treatments
    are needed.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.